利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

11 条记录 (耗时 0.012 秒)

    A MEDICINAL COMPOSITION OF EXTRACT OF SEED OF EMBLICA OFFICINALIS AND METHOD OF PREPARING THE SAME
    2.
    发明公开
    A MEDICINAL COMPOSITION OF EXTRACT OF SEED OF EMBLICA OFFICINALIS AND METHOD OF PREPARING THE SAME 审中-公开
    其制造余甘子，巴戟种子提取液和方法的药物组合物

    公开(公告)号：EP3068412A1

    公开(公告)日：2016-09-21

    申请号：EP14851616.4

    申请日：2014-10-07

    申请人： Antony, Benny

    发明人： Antony, Benny

    IPC分类号： A61K36/00 ,  A61K36/47

    CPC分类号： A61K36/47

    摘要： A composition having an extract of seed of
    Emblica officinalis . Methods of preparing extract of seed of
    Emblica officinalis . An amla seed blend composition having various ratios of extracts of seeds of
    Emblica officinalis . Nutraceutical or pharmaceutical methods for decreasing the total cholesterol, decreasing triglyceride, decreasing blood glucose level, enhancing HDL-C levels, increasing the HDL-C level to total cholesterol ratio, lowering LDL- C levels, decreasing the CRP level, decreasing the intima media thickening, reducing hair fall in mammals especially human beings. The extract of seed of
    Emblica officinalis , or the amla seed blend composition is more effective compared to extracts prepared from fruits of
    Emblica officinalis .

    摘要翻译： 具有提取余甘厚朴的种子的组合物。 准备余甘厚朴种子提取物的方法。 在余甘子种子共混组合物具有余甘厚朴的种子的提取物的各种比率。 用于降低总胆固醇，甘油三酯减少，降低血糖水平，提高HDL-C水平，增加HDL-C水平的总胆固醇的比例，降低LDL C水平，降低了CRP水平，减少内膜媒体营养品或药物的方法 增厚，在哺乳动物中减少hairfall爱尤其是人类。 余甘子种子的提取物巴戟或余甘子种子共混组合物是更有效的与从余甘厚朴的水果制备的提取物。

    FORMULATION OF CURCUMIN WITH ENHANCED BIOAVAILABILITY OF CURCUMIN AND METHOD OF PREPARATION AND TREATMENT THEREOF
    7.
    发明公开
    FORMULATION OF CURCUMIN WITH ENHANCED BIOAVAILABILITY OF CURCUMIN AND METHOD OF PREPARATION AND TREATMENT THEREOF 有权
    姜黄素生物利用度增加与用于生产和加工姜黄素和方法表达式

    公开(公告)号：EP2555787A2

    公开(公告)日：2013-02-13

    申请号：EP11765166.1

    申请日：2011-04-04

    申请人： Antony, Benny

    发明人： Antony, Benny

    IPC分类号： A61K36/9066

    CPC分类号： A61K36/9066

    摘要： A formulation of curcuminoid with essential oil of turmeric to enhance the bioavailability and to augment the biological activity of curcumin is disclosed, wherein curcumin is the main constituent of curcuminoid and Ar-turmerone is the main constituent of the essential oil of turmeric. The use of the formulation in the manufacture of medicament for the treatment of a variety of diseases is also disclosed.